Responses to human CGRP, ADM, and PAMP in human thymic arteries

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Champion, Hunter C ^a   Bivalacqua, Trinity J ^a   Pierce, Robert L ^a   Murphy, William A ^a   Coy, David H ^a   Hyman, Albert L ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

CGRP1 receptor; Human thymus; Vascular endothelium; Vascular tone

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEPTIDE DERIVATIVE; PROADRENOMEDULLIN; PROADRENOMEDULLIN AMINO TERMINAL 20 PEPTIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; BLOOD VESSEL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM LESION; ENZYME MECHANISM; HORMONE ACTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYMUS;

EID: 0037305859     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00337.2002     Document Type: Article

References (36)

1. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.
2. 2+-dependent agonist stimulated secretion of human adrenal glands. Hypertension 33: 1185-1189, 1999.
3. Brunner F, Scmidt K, Nielsen EB, and Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther 177: 48-53, 1996.
4. 2-terminal 20 peptide in the hindquarters vascular bed of the rat. Peptides 8: 513-518, 1997.
5. 2-terminal 20 peptide has cAMP-mediated vasodilator activity in the mesenteric vascular bed of the cat. Peptides 17: 379-387, 1996.
6. 2-terminal 20 peptide, a product of the adrenomedullin gene, has direct vasodilator activity in the cat. Am J Physiol Regul Integr Comp Physiol 272:R1047-R1054, 1997.
7. Champion HC, Santiago JA, Murphy WA, Coy DH, and Kadowitz PJ. Adrenomedullin (22-52) antagonizes vasodilator responses to calcitonin gene-related peptide but not adrenomedullin in the cat. Am J Physiol Regul Integr Comp Physiol 272: R234-R242, 1997.
8. Charles CJ, Nicholls MG, Rademaker MT, and Richards AM. Comparative actions of adrenomedullin and nitroprusside: interactions with ANG II and norepinephrine. Am J Physiol Regul Integr Comp Physiol 281: R1887-R1894, 2001.
9. Cockroft JR, Noon JP, Gardner-Medwin J, and Bennett T. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels. Br J Clin Pharmacol 44: 57-60, 1997.
10. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, and Ignarro LJ. Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219: 181-186, 1981.
11. Han ZQ, Coppock HA, Smith DW, Van Noorden S, Makgoba MW, Nichol CG, and Legon S. The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J Mol Endocrinol 18: 267-272, 1997.
12. Hofbauer KH, Jensen BL, Kurtz A, and Sandner P. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol Regul Integr Comp Physiol 278: R513-R519, 2000.
13. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, and Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338: 6-10, 1994.
14. Ishii-Nozawa R, Shinozuka K, Kunitomo M, Hashimoto T, and Takeuchi K. Participation of cAMP in the facilitatory action of β,α-methylene ATP on the noradrenaline release from rabbit ear artery. Life Sci 765: 2743-2753, 1999.
15. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, and Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94: 2158-2161, 1994.
16. Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, and Eto T. Adrenomedullin stimulates cyclase AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 200: 642-646, 1994.
17. Iwasaki H, Hirata Y, Iwashina M, Sato K, and Marumo F. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology 137: 3045-3050, 1996.
18. Jougasaki M, Rodeheffer RJ, Redfield MM, Yamamoto K, Wei C, McKinley LJ, and Burnett JC. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 97: 2370-2376, 1996.
19. Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, Kangawa K, Yamamoto Y, Kobayashi H, Eto T, and Wada A. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 64: 459-561, 1995.
20. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, and Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-560, 1993.
21. Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H, and Eto T. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett 338: 306-310, 1994.
22. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, and Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194: 720-725, 1993.
23. Kohno M, Hanehira T, Kanoi H, Horio T, Yokokawa K, Ikeda M, Minami M, Yasunari K, and Yoshikawa J. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27: 102-107, 1996.
24. Kuwasako K, Kitamura K, Ichiki Y, Kato J, Kangawa K, Matsuo H, and Eto T. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Biochem Biophys Res Commun 211: 694-699, 1995.
25. Marie JC, Wokkach A, Condray AM, Chastre E, Berrihakinin S, and Gespach C. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in human thymus and thymomas from myasthenia gravis patients. J Immunol 162: 2103-2112, 1999.
26. Nishikimi T, Yoshihara F, Kanazawa A, Okano I, Horio T, Nagaya N, Yutani C, Matsuo H, Matsuoka H, and Kangawa K. Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. Am J Physiol Regul Integr Comp Physiol 281: R2079-R2087, 2001.
27. Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K, Sata M, Kangawa K, Matsuo H, Goto A, Kitamura T, and Hirata Y. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 89: 63-70, 2001.
28. Nossaman BD, Feng C, Kaye AD, De Witt BJ, Coy DH, Murphy WA, and Kadowitz PJ. Pulmonary vasodilator responses to adrenomedullin are reduced by nitric oxide synthetase inhibitors in the rat but not in the cat. Am J Physiol Lung Cell Mol Physiol 270: L782-L789, 1996.
29. Poyner D. Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol Sci 16: 424-428, 1995.
30. + currents in rabbit arterial smooth muscle via protein kinase. J Physiol 475: 9-13, 1994.
31. Rothermel JD, Jasatorff B, and Botelho LH. Inhibition of glucagon-induced glyco-genolysis in isolated rat hepatocytes by the Rp diasteromer of cyclic 3′,5′-phosphorothioate. J Biol Chem 259: 8151-8155, 1984.
32. Sams A, Knyihar-Csillik E, Engberg J, Szok D, Tajti J, Bodi F, Edvinsson L, Vecsei L, and Jansen-Olesen I. CGRP and adrenomedullin receptor populations in human cerebral arteries: in vitro pharmacological and molecular investigations in different artery sizes. Eur J Pharmacol 408: 183-193, 2000.
33. Shimosawa T and Fujita T. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension 28: 325-329, 1996.
34. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest 96: 1672-1676, 1995.
35. Vari RC, Adkins SD, and Samson WK. Renal effects of adrenomedullin in the rat. Proc Soc Exp Biol Med 211: 178-183, 1995.
36. Washimine H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K, Matsuo H, and Eto T. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem Biophys Res Commun 202: 1081-1087, 1994.